Publication

Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Qi Wang, Medical School of Nanjing UniversityYang Zhang, Medical School of Nanjing UniversityBolei Zhang, Nanjing University of Post and TeleCommunicationsYao Fu, Medical School of Nanjing UniversityXiaozhi Zhao, Medical School of Nanjing UniversityJing Zhang, Medical School of Nanjing UniversityKe Zuo, Medical School of Nanjing UniversityYuexian Xing, Medical School of Nanjing UniversitySong Jiang, Medical School of Nanjing UniversityZhaohui Qin, Emory UniversityErguang Li, Medical School of Nanjing UniversityHongqian Guo, Medical School of Nanjing UniversityZhihong Liu, Medical School of Nanjing UniversityJingping Yang, Medical School of Nanjing University
Language
  • English
Date
  • 2022-12-01
Publisher
  • Springer Nature
Publication Version
Copyright Statement
  • © The Author(s) 2022
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 13
Issue
  • 1
Start Page
  • 31
End Page
  • 31
Grant/Funding Information
  • We are grateful to support from the National Natural Science Foundation of China (81500515, J.Y.), Natural Science Foundation of Jiangsu Province (BK20150591, J.Y.), Nanjing University and Emory University Collaborative Research Grants (NE2019003, J.Y.), the Fundamental Research Funds for the Central University (021114380172, J.Y.), Jiangsu Clinical Medical Center (innovation platform, YXZXA2016003, Z.L.), The Open Project of Jiangsu Biobank of Clinical Resources (JSRB2021-01, J.Y.).
Supplemental Material (URL)
Abstract
  • Papillary renal cell carcinoma (pRCC) is the most heterogenous renal cell carcinoma. Patient survival varies and no effective therapies for advanced pRCC exist. Histological and molecular characterization studies have highlighted the heterogeneity of pRCC tumours. Recent studies identified the proximal tubule (PT) cell as a cell-of-origin for pRCC. However, it remains elusive whether other pRCC subtypes have different cell-of-origin. Here, by obtaining genome-wide chromatin accessibility profiles of normal human kidney cells using single-cell transposase-accessible chromatin-sequencing and comparing the profiles with pRCC samples, we discover that besides PT cells, pRCC can also originate from kidney collecting duct principal cells. We show pRCCs with different cell-of-origin exhibit different molecular characteristics and clinical behaviors. Further, metabolic reprogramming appears to mediate the progression of pRCC to the advanced state. Here, our results suggest that determining cell-of-origin and monitoring origin-dependent metabolism could potentially be useful for early diagnosis and treatment of pRCC.
Author Notes
Keywords
Research Categories
  • Health Sciences, Public Health
  • Biology, Biostatistics
  • Computer Science
  • Health Sciences, Pathology

Tools

Relations

In Collection:

Items